Delivery Order SPE2DB20D3103-SPE2DB23FP1E5
- Not listed
- This federal contract award, valued at $1,209.71, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Clobazam 2.5 mg/ml suspension in 120 ml quantities. This is a Firm Fixed Price Delivery Order contract with a completion date of December 22, 2023. The contract was awarded on December 21, 2023 and was not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,849.72 delivery order is for the supply of Clobazam 2.5 mg/ml suspension in 120 ml bottles. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC serves as the primary vehicle for...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The contract, valued at $1,567.49, is for the provision of clobazam 10 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential...
- This federal contract award, valued at $1,210.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Clobazam 2.5 mg/ml suspension in 120 ml bottles. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of October 18, 2023. This award is not associated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds two...
- This federal contract award, with ID SPE2DB22D3016|SPE2DB24FADX1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,414.60 delivery order contract is for the supply of Clobazam 2.5 mg/mL suspension, a pharmaceutical product, with a completion date of November 22, 2023. The contract is a firm fixed-price arrangement and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,584.20 firm fixed-price delivery order is for the supply of 4,568,143,444 units of the prescription medication clobazam 10 mg tablets. The contract has an ultimate completion date of May 6, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,303.72, is a delivery order for the supply of 4,567,915,590 units of the medication Clobazam 10 mg Tablet. The contract has a firm fixed price and an ultimate completion date of April 16, 2025. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The contract is a $12,015.56 firm fixed-price delivery order for the supply of 100 tablets of the medication clobazam 10 mg. The contract has an ultimate completion date of July 14, 2025 and was awarded on July 11, 2025. This contract is not set aside and was competitively...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a prime contractor. The contract is a firm fixed price delivery order with a ceiling value of $3,897.26 for the supply of 4,564,085,629 units of the medication Clobazam 10 mg tablets. The award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA...
- This is a $1,330.65 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 2.5 mg/ml clobazam suspension in a 120 ml bottle. The delivery order has an ultimate completion date of July 7, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP1E5Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,321.96 firm fixed-price delivery order is for the supply of Clobazam 2.5 mg/mL suspension in 120 mL bottles. The contract has an ultimate completion date of July 26, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/25/23 |